- Home
- FBIO vs PMVP Comparison
FBIO vs PMVP Comparison
Compare FBIO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIO
- PMVP
- Stock Information
- Founded
- FBIO 2006
- PMVP 2013
- Country
- FBIO United States
- PMVP United States
- Employees
- FBIO N/A
- PMVP N/A
- Industry
- FBIO Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- FBIO Health Care
- PMVP Health Care
- Exchange
- FBIO Nasdaq
- PMVP Nasdaq
- Market Cap
- FBIO 88.7M
- PMVP 74.7M
- IPO Year
- FBIO N/A
- PMVP 2020
- Fundamental
- Price
- FBIO $2.44
- PMVP $1.40
- Analyst Decision
- FBIO Strong Buy
- PMVP Strong Buy
- Analyst Count
- FBIO 2
- PMVP 1
- Target Price
- FBIO $16.50
- PMVP $5.00
- AVG Volume (30 Days)
- FBIO 487.6K
- PMVP 767.8K
- Earning Date
- FBIO 11-12-2025
- PMVP 11-07-2025
- Dividend Yield
- FBIO N/A
- PMVP N/A
- EPS Growth
- FBIO N/A
- PMVP N/A
- EPS
- FBIO N/A
- PMVP N/A
- Revenue
- FBIO $59,301,000.00
- PMVP N/A
- Revenue This Year
- FBIO $31.85
- PMVP N/A
- Revenue Next Year
- FBIO $44.43
- PMVP N/A
- P/E Ratio
- FBIO N/A
- PMVP N/A
- Revenue Growth
- FBIO N/A
- PMVP N/A
- 52 Week Low
- FBIO $1.33
- PMVP $0.81
- 52 Week High
- FBIO $4.20
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- FBIO 36.08
- PMVP 45.91
- Support Level
- FBIO $2.47
- PMVP $1.38
- Resistance Level
- FBIO $2.65
- PMVP $1.67
- Average True Range (ATR)
- FBIO 0.14
- PMVP 0.09
- MACD
- FBIO -0.02
- PMVP -0.01
- Stochastic Oscillator
- FBIO 9.80
- PMVP 6.90
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.